Why Merlyn Exists
The global health architecture built over 25 years is fracturing. USAID has been dismantled. Bilateral donors are retrenching. The Gates Foundation has announced plans to wind down by 2045. African governments cannot absorb the shortfall — health budgets are already under pressure from debt service and post-COVID fiscal strain. And pharmaceutical companies, lacking credible market intelligence in a challenging operating environment, are reducing their commercial presence across the Global South.
But the retreat of donor funding is not just a crisis. It is also a clarifying moment. For decades, the aid model masked a deeper structural failure: the commercial market infrastructure that would allow essential health products to reach patients sustainably — independent of donor support — was never built. The data infrastructure to underpin it was never built either.
African governments, regional bodies, and health innovators are now actively trying to build it. The AU and individual countries are investing in sovereign procurement capacity, local manufacturing, and stronger health systems. What they need — and what has never existed — is the intelligence infrastructure to support those ambitions: dynamic, integrated, and designed to help leaders make decisions with confidence rather than guesswork.
Merlyn AI exists to build that infrastructure. Not as an outside solution arriving to fill a gap, but as a platform built on 20 years of relationships with the governments, health agencies, and market actors who are doing the building.
Why Merlyn Exists
The global health architecture built over 25 years is fracturing. USAID has been dismantled. Bilateral donors are retrenching. The Gates Foundation has announced plans to wind down by 2045. African governments cannot absorb the shortfall — health budgets are already under pressure from debt service and post-COVID fiscal strain. And pharmaceutical companies, lacking credible market intelligence in a challenging operating environment, are reducing their commercial presence across the Global South.
But the retreat of donor funding is not just a crisis. It is also a clarifying moment. For decades, the aid model masked a deeper structural failure: the commercial market infrastructure that would allow essential health products to reach patients sustainably — independent of donor support — was never built. The data infrastructure to underpin it was never built either.
African governments, regional bodies, and health innovators are now actively trying to build it. The AU and individual countries are investing in sovereign procurement capacity, local manufacturing, and stronger health systems. What they need — and what has never existed — is the intelligence infrastructure to support those ambitions: dynamic, integrated, and designed to help leaders make decisions with confidence rather than guesswork.
Merlyn AI exists to build that infrastructure. Not as an outside solution arriving to fill a gap, but as a platform built on 20 years of relationships with the governments, health agencies, and market actors who are doing the building.
Our Mission: Merlyn AI is building the intelligence infrastructure that enables equitable access to life-saving interventions and unlocks commercial success for the businesses delivering them.
Dynamic, integrated, and designed to create the future of global health, not just predict it.
Let's talk.
The global health field has needed this for 20 years. If you'd like to help build it - as a funder, investor, partner, or customer - we'd love to hear from you.
Let's talk.
The global health field has needed this for 20 years. If you'd like to help build it - as a funder, investor, partner, or customer - we'd love to hear from you.
Let's talk.
The global health field has needed this for 20 years. If you'd like to help build it - as a funder, investor, partner, or customer - we'd love to hear from you.